Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Eight Weeks of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07696247 is registered in ClinicalTrials.gov with Universidad Autonoma de Queretaro as lead sponsor.

NCT NCT07696247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Eight Weeks of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Universidad Autonoma de Queretaro
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2024
Completion date
August 1, 2026
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut microbiota, insulin resistance, metabolic syndrome, prebiotic, type 2 diabetes